ArticleCureus2021

C-Reactive Protein Is a Poor Marker of Baseline Inflammation in Prostate Cancer and Response to Radiotherapy or Androgen Ablation.

Garrett L Jensen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.